Trial intelligence / Profile preview

Oxymetazoline vs Epinephrine in Endoscopic Sinus Surgery

NCT03228914Phase 4Completed

Sponsor
UTHealth Houston
Start
Jun 2018
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Mucinex Full Force Nasal Spray in chronic rhinosinusitis (CRS), sponsored by UTHealth Houston. Started Jun 2018; status: completed.

02

Drugs

Mucinex Full Force Nasal Spray
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on NCT03228914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03228914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call